Correlation Between Aadi Bioscience and Acer Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and Acer Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and Acer Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aadi Bioscience and Acer Therapeutics, you can compare the effects of market volatilities on Aadi Bioscience and Acer Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of Acer Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and Acer Therapeutics.
Diversification Opportunities for Aadi Bioscience and Acer Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aadi and Acer is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and Acer Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer Therapeutics and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with Acer Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer Therapeutics has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and Acer Therapeutics go up and down completely randomly.
Pair Corralation between Aadi Bioscience and Acer Therapeutics
If you would invest 168.00 in Aadi Bioscience on January 18, 2024 and sell it today you would earn a total of 14.00 from holding Aadi Bioscience or generate 8.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Aadi Bioscience vs. Acer Therapeutics
Performance |
Timeline |
Aadi Bioscience |
Acer Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aadi Bioscience and Acer Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aadi Bioscience and Acer Therapeutics
The main advantage of trading using opposite Aadi Bioscience and Acer Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, Acer Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will offset losses from the drop in Acer Therapeutics' long position.Aadi Bioscience vs. Anebulo Pharmaceuticals | Aadi Bioscience vs. Adagene | Aadi Bioscience vs. Acrivon Therapeutics Common | Aadi Bioscience vs. AnaptysBio |
Acer Therapeutics vs. NRx Pharmaceuticals | Acer Therapeutics vs. Pasithea Therapeutics Corp | Acer Therapeutics vs. SAB Biotherapeutics | Acer Therapeutics vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |